News and Events

Available for Download

f5 Therapeutics Closes Seed Round with Viva BioInnovator

f5 Therapeutics Announces Selection as a San Diego ’Cool Company’ Class of 2021

f5 Therapeutics Inc Launches Scientific Advisory Board with the Appointment of Dr. Paul Pockros

f5 Therapeutics Announces Selection as San Diego 'Cool Company' Class of 2022-Wins Award for Second Year in a Row